Gaush Meditech Ltd (stock code: 02407) released its monthly return for the period ended 31 October 2025. The report indicates that the authorized share capital remained at 500,000,000 ordinary shares, with a par value of USD 0.0001 per share, totaling USD 50,000. There were no changes in the issued share capital or treasury shares, with 147,887,869 shares issued at both the beginning and end of the month.

According to the filing, no movements occurred under share option schemes, warrants, or convertible securities, and no additional agreements or arrangements involving the issuance of shares were noted during October 2025. The company also confirmed compliance with all relevant listing rules and regulatory requirements.